Published in Cold Spring Harb Perspect Med on November 03, 2014
Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.91
Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases. Front Microbiol (2015) 0.78
An Evolutionary-Based Framework for Analyzing Mold and Dampness-Associated Symptoms in DMHS. Front Immunol (2017) 0.75
Antifungal Immunological Defenses in Newborns. Front Immunol (2017) 0.75
Challenges and Strategies for Proteome Analysis of the Interaction of Human Pathogenic Fungi with Host Immune Cells. Proteomes (2015) 0.75
Amplification of TLO Mediator Subunit Genes Facilitate Filamentous Growth in Candida Spp. PLoS Genet (2016) 0.75
Neutrophil extracellular traps kill bacteria. Science (2004) 23.64
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS (2009) 16.37
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis (2005) 13.97
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Zygomycetes in human disease. Clin Microbiol Rev (2000) 9.80
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81
Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev (2007) 6.41
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium. Nature (2010) 5.79
Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev (2005) 5.77
Molecular evidence for the early colonization of land by fungi and plants. Science (2001) 5.49
White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell (2002) 5.36
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature (2005) 5.11
Virulence factors of Candida albicans. Trends Microbiol (2001) 5.01
Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains. Science (2000) 4.84
The dermatophytes. Clin Microbiol Rev (1995) 4.59
Sex increases the efficacy of natural selection in experimental yeast populations. Nature (2005) 4.31
Glomalean fungi from the Ordovician. Science (2000) 4.16
Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science (1999) 4.14
Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science (1999) 4.00
The distinct morphogenic states of Candida albicans. Trends Microbiol (2004) 3.86
Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet (2010) 3.65
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect (2002) 3.63
Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood (2005) 3.57
Global control of dimorphism and virulence in fungi. Science (2006) 3.50
Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol (1990) 3.47
Fusarium infections in immunocompromised patients. Clin Microbiol Rev (2007) 3.44
Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun (1995) 3.43
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A (2001) 3.37
Fungal community analysis by large-scale sequencing of environmental samples. Appl Environ Microbiol (2005) 3.37
Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis (2003) 3.34
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect (2004) 3.25
Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis (1995) 3.13
Fatal fungus infections complicating other diseases. Am J Clin Pathol (1955) 3.08
Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature (2009) 3.07
Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev (2000) 3.05
Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol (1991) 3.02
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev (2008) 2.96
The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains. PLoS Biol (2008) 2.78
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol (2009) 2.74
Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell (2008) 2.71
Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A (2002) 2.68
Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog (2010) 2.67
A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog (2006) 2.65
Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell (2006) 2.55
Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science (2000) 2.54
Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit. Med Mycol (2008) 2.46
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest (1993) 2.45
Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol (2003) 2.44
Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell (2007) 2.42
Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci U S A (2007) 2.34
Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg Infect Dis (2007) 2.33
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog (2010) 2.28
Adhesion in Candida spp. Cell Microbiol (2002) 2.24
Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy (1976) 2.17
Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med (2012) 2.12
Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration. Proc Natl Acad Sci U S A (2001) 2.12
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev (2011) 2.07
RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol Microbiol (2004) 2.06
Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol (2011) 2.05
Blastomycosis. Infect Dis Clin North Am (2003) 2.04
Fungal cell gigantism during mammalian infection. PLoS Pathog (2010) 2.04
Host-pathogen interactions: the attributes of virulence. J Infect Dis (2001) 2.00
Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother (2006) 1.99
Mutualistic mycorrhiza-like symbiosis in the most ancient group of land plants. Nat Commun (2010) 1.98
Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun (1984) 1.97
Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses (2005) 1.96
Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans. Nature (2009) 1.91
Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis (2003) 1.91
A REVIEW OF THE GENUS CANDIDA. Bacteriol Rev (1960) 1.84
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol (1998) 1.83
A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe (2011) 1.80
Phylogenetic relationships of varieties and geographical groups of the human pathogenic fungus Histoplasma capsulatum Darling. J Clin Microbiol (1999) 1.78
rodletless mutants of Aspergillus fumigatus. Infect Immun (1994) 1.77
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem (2005) 1.77
Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator. Proc Natl Acad Sci U S A (2008) 1.73
Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis (2008) 1.72
Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol (2003) 1.68
Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Fungal Genet Biol (2005) 1.68
Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67
Drosophila hemopoiesis and cellular immunity. J Immunol (2007) 1.65
Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci U S A (2000) 1.65
Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis (2012) 1.62
Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. J Infect Dis (1985) 1.58
Moniliasis following antibiotic therapy. Lancet (1954) 1.56
Global warming will bring new fungal diseases for mammals. MBio (2010) 1.56
Gastrointestinal zygomycotic infection caused by Basidiobolus ranarum: case report and review. Clin Infect Dis (1999) 1.54
Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell (2010) 1.52
Epidemiology of superficial fungal infections. Clin Dermatol (2010) 1.52
Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis (2009) 1.51
An immunoinhibitory cell wall glycoprotein (mannan) from Trichophyton rubrum. J Invest Dermatol (1991) 1.49
What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol (2010) 1.48
Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev (2013) 1.44
Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun (2003) 1.44
Fungi evolved right on track. Mycologia (2009) 1.44
Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol (2007) 1.41